In the tRF-1:28-Val-CAC-2 mimic group, a significant increase in tumor weight was evident relative to control mice, whereas the weight of tumors expressing the tRF-1:28-Val-CAC-2 inhibitor construct was significantly reduced (Figures 3A–D). This evidence concerns the gene TERF1 and neoplasm.